Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack
- PMID: 34596579
- PMCID: PMC8630766
- DOI: 10.1530/EC-21-0294
Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack
Abstract
Objective: Pheochromocytomas are a hallmark feature of von Hippel-Lindau disease (vHL). To our knowledge, this is the first systematic review with meta-analysis evaluating the frequency of pheochromocytomas and/or paragangliomas (PPGLs) in patients with vHL, as well as among patients with different vHL subtypes.
Design: Systematic review with meta-analysis.
Methods: We searched on MEDLINE, Scopus, and Web of Science. We included primary studies assessing participants with vHL and reporting on the frequency of PPGL. We performed random-effects meta-analysis to quantitatively assess the frequency of PPGL, followed by meta-regression and subgroup analysis. Risk of bias analysis was performed to assess primary studies' methodological quality.
Results: We included 80 primary studies. In 4263 patients with vHL, the pooled frequency of PPGL was 19.4% (95% CI = 15.9-23.6%, I2 = 86.1%). The frequency increased to 60.0% in patients with vHL type 2 (95% CI = 53.4-66.3%, I2 = 54.6%) and was determined to be of 58.2% in patients with vHL type 2A (95% CI = 49.7-66.3%, I2 = 36.2%), compared to 49.8% in vHL type 2B (95% CI = 39.9-59.7%, I2 = 42.7%), and 84.1% in vHL type 2C (95% CI = 75.1-93.1%, I2 = 0%). In meta-regression analysis, more recent studies were associated with a higher frequency of PPGL. All studies had at least one internal validity item classified as 'high risk of bias,' with 13% studies having low risk of bias in all external validity items.
Conclusions: PPGLs are a common manifestation of vHL. Despite methodological limitations and differences across primary studies, our results point to the importance of PPGL screening in patients with vHL.
Keywords: frequency; paraganglioma; pheochromocytoma; systematic; von Hippel–Lindau.
Figures


Similar articles
-
Surveillance in Children and Adolescents with von Hippel-Lindau (VHL)-Related Pheochromocytomas and Paragangliomas: A Survey of MET and Freiburg-VHL Registries in Germany.J Kidney Cancer VHL. 2024 Nov 20;11(4):15-27. doi: 10.15586/jkcvhl.v11i4.362. eCollection 2024. J Kidney Cancer VHL. 2024. PMID: 39588063 Free PMC article.
-
Germline mutations in the new E1' cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma.J Med Genet. 2020 Nov;57(11):752-759. doi: 10.1136/jmedgenet-2019-106519. Epub 2020 Jan 29. J Med Genet. 2020. PMID: 31996412 Free PMC article.
-
Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome.J Clin Endocrinol Metab. 2009 Nov;94(11):4367-71. doi: 10.1210/jc.2009-1479. Epub 2009 Oct 6. J Clin Endocrinol Metab. 2009. PMID: 19808854
-
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.Front Endocrinol (Lausanne). 2020 Nov 24;11:586857. doi: 10.3389/fendo.2020.586857. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33329393 Free PMC article. Review.
-
Von Hippel-Lindau disease: a single gene, several hereditary tumors.J Endocrinol Invest. 2018 Jan;41(1):21-31. doi: 10.1007/s40618-017-0683-1. Epub 2017 Jun 6. J Endocrinol Invest. 2018. PMID: 28589383 Review.
Cited by
-
New Developments in VHL-Associated Neuroendocrine Neoplasms.Curr Oncol Rep. 2025 Jan;27(1):59-67. doi: 10.1007/s11912-024-01631-5. Epub 2025 Jan 5. Curr Oncol Rep. 2025. PMID: 39757325 Review.
-
Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes.Endocr Oncol. 2022 Jun 28;2(1):R65-R77. doi: 10.1530/EO-22-0044. eCollection 2022 Jan. Endocr Oncol. 2022. PMID: 37435466 Free PMC article. Review.
-
A New Era of Management of Von Hippel-Lindau Disease-Associated Tumors With Belzutifan.Clin J Oncol Nurs. 2025 Jan 17;29(1):25-29. doi: 10.1188/25.CJON.25-29. Clin J Oncol Nurs. 2025. PMID: 39933087 Free PMC article.
-
Clinical, genetic, radiological characteristics and management of mediastinal paragangliomas: a literature review and case series.Endocr Relat Cancer. 2025 Mar 24;32(5):e240279. doi: 10.1530/ERC-24-0279. Print 2025 May 1. Endocr Relat Cancer. 2025. PMID: 40063004 Free PMC article. Review.
-
Current prospects of hereditary adrenal tumors: towards better clinical management.Hered Cancer Clin Pract. 2024 Mar 26;22(1):4. doi: 10.1186/s13053-024-00276-6. Hered Cancer Clin Pract. 2024. PMID: 38532453 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources